SPONSOR
H. Lee Moffitt Cancer Center and Research Institute
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 3
Conditions studied: Smoking CessationAlcohol UseGastroEsophageal CancerChronic Graft-versus-host Disease (cGVHD)Breast CancerDiffuse Large B Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Smoking Cessation, Alcohol Use, GastroEsophageal Cancer, Chronic Graft-versus-host Disease (cGVHD).
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — H. Lee Moffitt Cancer Center and Research Institute
How many clinical trials has H. Lee Moffitt Cancer Center and Research Institute sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by H. Lee Moffitt Cancer Center and Research Institute, of which 5 are actively recruiting participants. These trials cover conditions including Smoking Cessation, Alcohol Use, GastroEsophageal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does H. Lee Moffitt Cancer Center and Research Institute research focus on?
H. Lee Moffitt Cancer Center and Research Institute clinical trials span Smoking Cessation, Alcohol Use, GastroEsophageal Cancer, Chronic Graft-versus-host Disease (cGVHD), Breast Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a H. Lee Moffitt Cancer Center and Research Institute clinical trial?
To participate in a H. Lee Moffitt Cancer Center and Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all H. Lee Moffitt Cancer Center and Research Institute trials with current recruitment status updated daily.
Clinical Trials by H. Lee Moffitt Cancer Center and Research Institute
NCT07447635
Recruiting
Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
Smoking Cessation
NCT06497569
Recruiting
Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
GastroEsophageal Cancer
NCT06660355 Phase 2
Recruiting
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
NCT07357298 Phase 3
Recruiting
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Breast Cancer
NCT05757219 Phase 2
Recruiting
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
Diffuse Large B Cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology